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bstract
The phenolics composition and inhibitory activity of Tetrapleura  tetraptera  fruit extract on xanthine oxidase (XO) and Fe2+-induced lipid
eroxidation in the kidney, liver and lungs tissues of rats were evaluated in  vitro. Phenolics (flavonoids and phenolic acids) were quantified
sing reverse-phase high performance liquid chromatrography coupled with diode array detection (HPLC-DAD). The XO and Fe2+-induced lipid
eroxidation inhibitory abilities of the extract were evaluated using spectrophotometric methods. The extract contained some flavonoids and
henolic acids, including catechin, epicatechin, rutin, quercetin, luteolin, apigenin; gallic, chlorogenic, caffeic and ellagic acids that are beneficial
o health. The extract inhibited XO in the kidney, liver and lungs tissues in a dose-dependent manner. The half-maximal inhibitory concentrations
IC50) of the extract on XO from the tissues varied significantly (P  < 0.05), and were in the order of liver > kidney > lungs. The extract also inhibited
e2+-induced lipid peroxidation in a dose-dependent pattern, having IC50 in the order of liver > lungs > kidney. T.  tetraptera  fruit extract could be promising nutraceutical for preventing and managing hyperuricaemia and the associated disease conditions, due to its ability to inhibit XO; this
ioactivity is attributable to combined effect of its flavonoids and phenolic acids.
 2015 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
Experimental evidence has shown that elevated concentra-
ion of uric acid, otherwise known as hyperuricaemia, leads to
he deposition of monosodium urate monohydrate crystals in
issue, especially joints, thereby resulting in gouty arthritis or
ric acid nephrolithiasis [1,2]. Gout is a chronic inflammatory∗ Corresponding author at: Biochemistry Unit, Department of Biosciences and
iotechnology, Kwara State University, Malete, P.M.B. 1530, Ilorin, Nigeria.
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rthritis characterized by elevated concentration of uric acid
n body fluids, resulting from the over-activity of xanthine
xidase (XO) [3]. It is also characterized with severe and
pisodic painful inflammation [4]: erythema and swelling [5].
pidemiological studies have shown that the overall burden
f the disease is increasing globally [2]. It is more prevalent
n men above 30 years of age and in women older than 50
ears [2,6]. Moreover, it has the propensity to reduce the
uality of life of these individuals [7]. In addition to gouty
rthritis, hyperuricaemia is also a well-established causative
actor for uric acid kidney stones and acute kidney failure [8].
ecent epidemiologic studies have also implicated chronic mild
yperuricaemia in the development of interstitial nephritis and
rogressive renal failure [9]. Furthermore, it is an independent
lsevier B.V. All rights reserved.
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isk factor for metabolic syndrome, cardiovascular disease,
ypertension, obesity, obstructive sleep apnea, stroke, vascular
ementia, and preeclampsia [10].
Xanthine oxidase (XO) (EC 1.1.3.22) catalyzes the oxidation
f hypoxanthine to xanthine and subsequently to uric acid [11]
n the purine nucleotides catabolism. Its re-oxidation involves
olecular oxygen which acts as electron acceptor, and during
his reaction, superoxide radical (O2•−) and hydrogen perox-
de (H2O2) are produced [12]. The O2•− is transformed into
2O2 and O2 either spontaneously or by the catalytic action
f superoxide dismutase. Thus, the over-activity of XO leads
o the deposition of uric acid in the susceptible tissues, and
his triggers the inflammatory pathways with a concomitant
elease of reactive oxygen species. Hence, gouty arthritis and
ther inflammatory diseases associated with hyperuricaemia are
haracterized by oxidative stress. The kidney, liver and lungs
re three major organs in mammals involved in metabolism
nd excretion, and previous studies have reported XO activ-
ty in the tissues of these organs [6,13,14]. Functionally, in
hese organs materials are chemically biotransformed and the
etabolic wastes, such as carbon dioxide, water, salt, urea and
ric acid, are removed from the body.
Clinically, anti-inflammatory agents are used to relieve the
ymptoms of gout, and XO inhibitors are used to block the syn-
hesis of uric acid. These two approaches are common treatments
f gout. Allopurinol, a purine analog, is the most common XO
nhibitor that functions to reduce serum urate level [1]. How-
ver, its use has some attendant side effects in patients, and for
his reason it is usually contraindicated in patients with kidney
r heart disease. The side effects include the risk of develop-
ng hypersensitivity syndrome that is characterized by renal
mpairment, hepatic dysfunction, fever, rashes, leucocytosis and
osinophilia [15]. These limitations of allopurinol have necessi-
ated research into alternative treatment strategies for gout that
ould be safer and effective. In this regard, medicinal plants are
idely used to treat gout, as previous studies have demonstrated
hat several of them with high level of flavonoids and other
henolics compounds possess XO inhibitory activity [16–18].
lant-derived polyphenolics with antioxidant potential, includ-
ng flavonoids and phenolic acids, can modulate the expression
f pro-inflammatory signals and ameliorate inflammatory dis-
ases such as arthritis [19,20].
Tetrapleura tetraptera, called “aidan” in the South-western
art of Nigeria, and “ihokiriho” by the Ngwa people in the South-
astern part of Nigeria, is a deciduous tree belonging to the
amily Mimosaceae. It is generally distributed in the lowland for-
st of tropical Africa. The fruits, made up of a fleshy pulp with
mall, brownish-black seeds, are green when tender and dark
rown when fully ripe and possess high nutritional value [21].
hen dry, they have a pleasant aroma, and therefore are used as
pice in Central and West Africa [22]. This spicy property makes
hem valuable for preparing soup for nursing mothers from the
rst day of birth to prevent post-partum contraction [23]. Pre-
ious studies have demonstrated that different parts of the plant
re used in ethnomedicine for the treatment of several ailments
ncluding diabetes mellitus, hypertension, intestinal parasites,
alaria, asthma, epilepsy, schistosomiasis, wound healing and
w
(uman Wellness 5 (2016) 17–23
rthritis [24,25]. Recent studies have also revealed that the pod
ossesses antioxidant and amylase inhibitory activities [21];
he fruits and barks extracts also have antioxidant activities
22].
The aforementioned health benefits of T.  tetraptera  make
t a promising functional food. Interestingly, functional foods
f plant origin have continued to receive considerable research
ttention in the recent time due to their nutritional quality, ther-
peutic effects and presumed safety [26]. Hence, to further
xplore the health benefits of T.  tetraptera, the present study
haracterized the phenolics of T.  tetraptera  fruit, and evaluated
he XO inhibitory activity of its phenolic extract in the kidney,
iver and lungs tissues of rats in  vitro.
.  Materials  and  methods
.1.  Samples  collection  and  preparation
Ripe fruits samples of T. tetraptera  were harvested from the
lant in Umueze area of Ekwereazu-Ngwa village in Obi-Ngwa
ocal government area of Abia State, Nigeria, in November,
014. The fruits were botanically identified and authenticated
t the herbarium of the Department of Botany, University of
badan, Nigeria. Subsequently, they were sun-dried for seven
ays, and the seeds were manually removed. The fruits were
ater milled into a fine particle size (0.5 mm) powder and packed
n air-tight plastic vials, and stored at −4 ◦C until analysis.
Methanol, formic acid, gallic acid, chlorogenic acid, caf-
eic acid and ellagic acid purchased from Merck (Darmstadt,
ermany). Catechin, epicatechin, quercetin, rutin, apigenin and
uteolin; xanthine and allopurinol were acquired from Sigma
hemical Co. (St. Louis, MO, USA). All other chemicals used
or analysis were of analytical grade.
.2.  Preparation  of  polyphenolics  extract
Polyphenolics extract of T.  tetraptera  fruits was prepared
ccording to the method described by Kuo et al. [27]. A portion
f T.  tetraptera  fruits powder (100 g) was extracted three suc-
essive times with 300 mL of methanol at 50 ◦C for 3 h, and
he samples were filtered after each extraction with Whatman
No. 2) filter paper. The combined extract was partitioned with
00 mL hexane in a separatory funnel to remove the lipids and
ome of the pigments. The aqueous phase was extracted three
imes with 180 mL ethyl acetate; after which it was evaporated to
ryness at 45 ◦C under reduced pressure in a rotary evaporator.
he residue from this step was redissolved in 250 mL water, and
yophilized to obtain approximately 5 g of T. tetraptera  fruits
olyphenolics extract. The percentage yield of the extract was
%.
.3.  Quantiﬁcation  of  phenolic  compounds  using
PLC-DADHigh performance liquid chromatography (HPLC-DAD)
as performed with a Shimadzu Prominence Auto Sampler
SIL-20A) HPLC system (Shimadzu, Kyoto, Japan), equipped
and H
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ith Shimadzu LC-20AT reciprocating pumps connected to a
GU 20A5 degasser with a CBM 20A integrator, SPD-M20A
iode array detector and LC solution 1.22 SP1 software.
Reverse phase chromatographic analysis was carried out
nder gradient conditions using C18 column (4.6 mm ×  150 mm)
acked with 5 m diameter particles; the mobile phase was
ater containing 1% formic acid (A) and methanol (B), and the
omposition gradient was: 13% of B until10 min, and changed
o obtain 20%, 30%, 50%, 60%, 70%, 20% and10% B at 20, 30,
0, 50, 60, 70 and 80 min, respectively, following the method
escribed by Menezes et al. [28] with slight modifications.
he T.  tetraptera  fruits extract and mobile phase were filtered
hrough 0.45 m membrane filter (Millipore) and then degassed
y ultrasonic bath prior to use. The extract was analyzed at
 concentration of 15 mg/mL. The flow rate was 0.7 mL/min,
nd the injection volume was 40 L. The wavelength were
54 nm for gallic acid, 280 nm for catechin and epicatechin,
27 nm for chlorogenic, caffeic and ellagic acids, and 365 nm
or quercetin, rutin, apigenin and luteolin. Stock solutions
f standards references were prepared in the HPLC mobile
hase at a concentration range of 0.030–0.450 mg/mL. The
hromatography peaks were confirmed by comparing their
etention time with those of reference standards and by DAD
pectra (210–500 nm). The calibration curves were gallic
cid: Y  = 11,964x  + 1283.5 (r  = 0.9999); chlorogenic acid:
 = 13,087x  + 1195.4 (r  = 0.9998); caffeic acid: Y  = 11,962x  +
273.8 (r  = 0.9996); ellagic acid: Y  = 12,643x  + 1327.6
r = 0.9995); catechin: Y = 13,470x  + 1195.3 (r  = 0.9999);
picatechin: Y  = 11,786x  + 1265.4 (r  = 0.9997); quercetin:
 = 12,762x  + 1373.8 (r  = 0.9998); rutin: Y = 13,194x  + 1197.0
r = 0.9999); apigenin: Y  = 13,471x  + 1195.6 (r  = 0.9994) and
uteolin: Y  = 12,763x  + 1347.9 (r  = 0.9999). All chromatography
perations were carried out at ambient temperature and in
riplicate.
The limit of detection (LOD) and limit of quantification
LOQ) were calculated based on the standard deviation of
he responses and the slope using three independent analyti-
al curves. LOD and LOQ were calculated as 3.3 and 10 σ/S,
espectively, where σ  is the standard deviation of the response
nd S  is the slope of the calibration curve [29].
.4.  Handling  of  experimental  animals
Adult male Wistar strain albino rats weighing 200–250 g were
sed in this study. The rats were procured from the experimen-
al animal breeding unit of Department of Veterinary Medicine,
niversity of Ibadan, Nigeria. The animals received humane
are according to the criteria outlined in the Guide for the
are and Use of Laboratory Animals prepared by the National
cademy of Science and published by the National Institute
f Health (USA) [30]. The guidelines were followed to ensure
he protection of the animals’ welfare during the experiment.
he rats were kept in a cage to acclimatize for 7 days, during
hich they were maintained at room temperature under the lab-
ratory conditions and were fed with standard diet and water
d libitum.
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.5.  Preparation  of  Kidney,  liver  and  lungs  tissues
omogenates  for  XO  and  lipid  peroxidation  inhibition
ssays
The kidney, liver and lungs tissues homogenates for XO and
ipid peroxidation inhibition assays were prepared following the
ethod described by Nakamura et al. [31]. The kidney, liver
nd lungs were rapidly excised after decapitation of the rats
nder mild ether anesthesia. Each tissue was washed in cold
.15 mol/L KCl, and blotted dry. Then a portion of 1 g of each
issue was homogenized in 9 volumes of ice-cold 50 mmol/L
ris–HCl buffer (pH 7.4) containing 1 mmol/L ethylene diamine
etraacetic acid (EDTA). A portion of the homogenate was cen-
rifuged for 10 min at 1400 ×  g to yield a low-speed supernatant
hat was used for the lipid peroxide assay. For the XO assay,
nother portion of the homogenate of each tissue was sonicated
wice on ice for 30 sesonds and then centrifuged at 10,000 ×  g
or 20 min at 4 ◦C to obtain the supernatant fraction used.
.6.  Xanthine  oxidase  inhibition  assay
The ability of the extract to inhibit XO was determined fol-
owing the method reported by Umamaheswari et al. [17] with
light modification. The reaction mixture consisted of 300 L
f 50 mmol/L sodium phosphate buffer (pH 7.5), 100 L of the
xtract at different concentrations (15, 30, 45 and 60 mg/mL) in
imethyl sulphoxide (DMSO), 100 L of freshly prepared tis-
ue enzyme preparation and 100 L of distilled water. The assay
ixture was pre-incubated at 37 ◦C for 15 min. Then, 200 L
f 0.15 mmol/L of xanthine solution (substrate) was added to
he mixture which was incubated at 37 ◦C for 30 min; this was
ollowed by the addition of 200 L of 0.5 mol/L HCl to termi-
ate the reaction. Allopurinol was used as a positive control for
he assay. A reference test containing 100 L of DMSO instead
f the extract was carried out in order to obtain the maximum
ric acid formation. The absorbance was measured at 295 nm
n a UV/VIS spectrophotometer against a blank prepared in the
ame way except that the enzyme solution was replaced with
he phosphate buffer. One unit (U) of this enzyme is defined as
he amount of enzyme required to form 1 mmol of uric acid per
in at the reaction conditions. The percentage XO inhibitory
ctivity of the extract was calculated thus:
 XO inhibition =
[ (A295reference −  A295sample)
A295reference
]
×  100.
here A295reference is the reference without the extract, and
295sample is the absorbance of test containing the extract.
.7.  Lipid  peroxidation  inhibition  assay
The ability of the extract to inhibit Fe2+-induced lipid per-
xidation in kidney, liver and lungs tissues homogenates of rats
as assayed according to the modified method of Ohkawa et al.32]. Briefly, to a reaction mixture containing 100 L of the
omogenate supernatant, 30 L of 0.1 mol/L Tris–HCl buffer
pH 7.4) and different concentrations of the extract, 30 L of
reshly prepared 25 mol/L ferric sulfate solution was added to
20 E.A. Irondi et al. / Food Science and Human Wellness 5 (2016) 17–23
Fig. 1. Representative high performance liquid chromatography profile of
T. tetraptera fruit. Gallic acid (peak 1), catechin (peak 2), chlorogenic acid
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Table 1
Phenolics composition of T. tetraptera fruits.
Phenolic compound mg/g LOD (g/mL) LOQ (g/mL)
Gallic acid 2.95 ± 0.01 0.009 0.030
Catechin 0.43 ± 0.03 0.017 0.056
Chlorogenic acid 0.21 ± 0.01 0.023 0.076
Caffeic acid 3.72 ± 0.02 0.026 0.085
Ellagic acid 3.69 ± 0.04 0.008 0.026
Epicatechin 1.38 ± 0.01 0.013 0.043
Rutin 1.74 ± 0.01 0.015 0.049
Quercetin 3.65 ± 0.03 0.029 0.097
Luteolin 0.45 ± 0.02 0.011 0.036
Apigenin 3.73 ± 0.01 0.018 0.059
Results are expressed as mean ± standard deviations (SD) of triplicate determi-
nations.
Table 2
Half-maximal inhibitory concentration (IC50) of T. tetraptera fruits extract on
xanthine oxidase activity in kidney, liver and lungs tissues of rats.
Tissue IC50 (g/mL)
Extract Allopurinol
Kidney 39.53 ± 1.02b 4.18 ± 0.11b
Liver 45.71 ± 1.44a 5.41 ± 0.13a
Lungs 33.87 ± 0.96c 3.26 ± 0.10c
Results are expressed as mean ± standard deviations (SD) of triplicate determi-
nations. Values with the different lowercase superscript letter along the same
column are significantly different (P < 0.05).
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Xpeak 3), caffeic acid (peak 4), ellagic acid (peak 5), epicatechin (peak 6), rutin
peak 7), quercetin (peak 8), luteolin (peak 9) and apigenin (peak 10).
nitiate lipid peroxidation. The volume was made up to 300 L
ith deionized water before incubation at 37 ◦C for 1 h. The
olor reaction was initiated by adding 300 L of 81 g/L sodium
uodecyl sulphate to the reaction mixture, followed by the addi-
ion of 600 L of acetic acid/HCl (pH 3.4) and 600 L of 0.8%
v/v) TBA (Thiobarbituric acid). This mixture was incubated
t 100 ◦C for 1 h. The absorbance of thiobarbituric acid reac-
ive species (TBARS) produced were measured at 532 nm in
n UV–Visible spectrophotometer. A reference test without the
lant extract was carried out in order to obtain the maximum
BARS formation. The decrease in the absorbance of test sam-
le in relation to the reference test was used to calculate the %
nhibition as follows:
 Inhibition =
[ (A532reference −  A532sample)
A532reference
]
×  100.
here A532reference is the absorbance of the reference without
he extract, and A532sample is the absorbance of test containing
he extract.
.8.  Statistical  analysis
Results of replicate experiments were expressed as
ean ±  standard deviation (SD). Analysis of variance (ANOVA)
as carried out on the result data at 95% confidence level
sing SPSS statistical software package, version 17. IC50 was
alculated from the % inhibition versus  extract concentration
on-linear regression curve of the extract.
.  Results
The HPLC chromatogram of T.  tetraptera  fruits (Fig. 1)
evealed the presence of the gallic acid (tR = 13.07 min;
eak 1), catechin (tR = 15.26 min; peak 2), chlorogenic acid
tR = 20.11 min; peak 3), caffeic acid (tR = 24.19; peak 4), ellagic
cid (tR = 29.87; peak 5), epicatechin (tR = 35.46 min; peak
), rutin (tR = 41.08 min; peak 7), quercetin (tR = 49.23 min;
eak 8), luteolin (tR = 55.16 min; peak 9) and apigenin
tR = 62.73 min; peak 10). The phenolics composition of the
ruits is shown in Table 1. The flavonoids were in the order of
pigenin > quercetin > rutin > epicatechin > luteolin > catechin;
i
tig. 2. Xanthine oxidase activity % inhibition versus T. tetraptera fruit extract
oncentration curve in kidney, liver and lungs tissues of rats.
hereas the phenolic acids were in the order of caffeic
cid > ellagic acid > gallic acid > chlorogenic acid.
The ability of the extract to inhibit XO in the kidney, liver
nd lungs tissues homogenates of rats was tested, and the result
s presented in Table 2 in terms of their half-maximal inhibitory
oncentration (IC50), in relation to allopurinol (positive control).
he IC50 of both the extract and allopurinol on the XO in the
omogenates of the three tissues varied significantly (P  < 0.05)
n the order of liver > kidney > lungs. The pattern of inhibition
f XO by the extract was dose-dependent as depicted in Fig. 2.
enerally, allopurinol had a stronger inhibitory ability on the
O than the extract.
As shown in Table 3, the extract also inhibited Fe2+-
nduced lipid peroxidation in the kidney, liver and lungs
issues homogenates of rats. Its IC50 values varied significantly
E.A. Irondi et al. / Food Science and H
Table 3
Half-maximal inhibitory concentration (IC50) of T. tetraptera fruits extract on
Fe2+-induced lipid peroxidation in the kidney, liver and lungs tissues of rats.
Tissue IC50 (g/mL)
Kidney 20.39 ± 1.19c
Liver 36.97 ± 2.06a
Lungs 26.65 ± 1.82b
Data represent the mean ± standard deviation of replicate readings. Values with
the different lowercase superscript letter along the column are significantly
different (P < 0.05).
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kig. 3. Fe2+-induced lipid peroxidation % inhibition versus T. tetraptera fruit
xtract concentration curve in kidney, liver and lungs tissues of rats.
P < 0.05) such that that of the liver (36.97 ±  2.06 g/mL) >
ungs (26.65 ±  1.82 g/mL) > kidney (20.39 ±  1.19 g/mL);
nd its pattern of inhibition was also dose-dependent as shown
n Fig. 3.
.  Discussion
Dietary spices are recognized as natural antioxidant agents
nd inhibitors of pro-oxidant enzymes such as XO. These ben-
ficial activities are attributable to the flavonoids and other
olyphenols present in the spices [33]. Hence, we evaluated the
nhibitory effect of the phenolic extract of T.  tetraptera  fruits,
 dietary spice, on XO and Fe2+-induced lipid peroxidation in
he kidney, liver, and lungs tissues of rats in  vitro. The important
oles the kidney, liver and lungs play as organs of metabolism and
xcretion in mammals, and the previously reported XO activity
n these organs [6,13], informed the choice of their homogenates
s the source of the enzyme.
The chromatographic analysis of phenolic compounds
Table 1) revealed that T.  tetraptera  fruits are rich in flavonoids
apigenin, quercetin, rutin, epicatechin, luteolin and catechin)
nd phenolic acids (caffeic acid, ellagic acid, gallic acid and
hlorogenic acid). These two classes of natural phenolic com-
ounds are regarded to be of pharmacological importance
34], as they possess diverse health benefits, including anti-
nflammatory activity [35]. They can modulate the expression of
ro-inflammatory signals and ameliorate inflammatory diseases
uch as arthritis like other natural polyphenolics [19,20]. As part
f their anti-inflammatory activity, polyphenolics including the
avonoids and phenolic acids have been reported to inhibit XO
ctivity by recent studies [33,36,37]. Probably, like allopurinol,
hey inhibit XO by binding at its purine binding site [38], thereby
d
d
h
tuman Wellness 5 (2016) 17–23 21
locking the ultimate formation of uric acid. In addition to their
bility to inhibit XO, phenolics are well-known for their antiox-
dant activities [39], and ability to inhibit Fe2+-induced lipid
eroxidation [34]. The flavonoids exhibit antioxidant activity
y acting as both electrons donors and terminators of chain
eactions; and this is due the hydroxyl groups they possess,
articularly at the 3′OH and 4′OH of their three-carbon chain
40,41]. Phenolic acids, on the other hand, have a phenolic ring
nd an organic carboxylic acid function [42], which make them
apable of stabilizing and delocalizing unpaired electrons [43].
hese distinguishing structural features make flavonoids and
henolic acids prominent antioxidant phenolic compounds.
Inhibitors of XO are used clinically for the treatment of hype-
uricaemia and gouty arthritis; as they help in reducing the levels
f uric acid in circulation, and vascular oxidative stress [44]. In
his regard, the efficacy of plant-derived polyphenolics in inhib-
ting XO and alleviating the resultant hyperuricaemia has been
eported; and as natural components of food, they are regarded
o be safer than synthetic XO inhibitors such as allopurinol [33].
heir inhibitory effect against XO has been attributed to the
ossibility of the C-5 and C-7 hydroxyl groups of flavones and
avonols to replace the C-2 and C-6 ones  of xanthine in the
O active site [45,46], due to the mutual inter-convertibility of
he carboxyl structures of xanthine to hydroxyl groups [47]. In
his study, the phenolic extract of T.  tetraptera  fruits effectively
nhibited XO in the kidney, liver and lungs tissues homogenates
f rats. Interestingly, the IC50 values of the extract on the XO
rom these three tissues (kidney: 39.53 ±  1.02 g/mL; liver:
5.71 ±  1.44 g/mL; lungs: 33.87 ±  0.96 g/mL) (Table 2) are
n the range of the IC50 values earlier reported for Erythrina
tricta leaves extract (21.2 g/mL) [17], and Olea  europaea
eaf extract (42 g/mL) [36] on XO. Furthermore, the order of
he IC50 values of the extract on the XO from these three tis-
ues (liver > kidney > lungs) may suggest a higher activity of the
O in the liver homogenate than in the kidney and the lungs
omogenates. This supports an earlier report that the distribu-
ion XO activity is highest in the liver followed by the kidney and
ther tissues, as demonstrated by Carro et al. [14]. Similarly, Liu
t al. [48] reported that XO is present in significant concentration
n the liver. It is noteworthy that apigenin, the most abundant of
he phenolics in T.  tetraptera  fruit from our HPLC-DAD result,
as earlier reported to possess the strongest XO inhibitory activ-
ty compared with other phenolics in O.  europaea  leaf extract
36].
Elevated XO activity enhances lipid peroxidation due to
he attendant excessive generation of reactive oxygen species
ROS), decreases in the levels of non-protein antioxidants
ncluding reduced glutathione (GSH), vitamin C and vitamin
; and the inflammation associated with neutrophil infiltration
31]. Lipid peroxidation is the oxidative damage of lipids, espe-
ially the polyunsaturated fatty acids that are very susceptible
o oxidative attack, by ROS and transition metal ions; and it is
nown to play a key role in cell injury [49]. This is due to the
iverse cytotoxic products, mostly aldehydes such as malon-
ialdehyde (MDA) it yields [50]. These cytotoxic aldehydes
ave been implicated in the pathogenesis of a number of oxida-
ive stress-induced inflammatory diseases [51] such as gouty
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rthritis. Under such condition, the antioxidant status of the
ffected tissues is attenuated; thereby over-exposing the cells to
xidative damage, and aggravating the inflammatory condition.
The peroxidation of membrane lipids and the consequent
xidative damage to cell membrane may disrupt the membrane
ransport, ionic channels, proteins and deactivate membrane-
ssociated enzymes; the membrane lipid bilayer itself may
ecome more permeable due to oxidative damage [33]. Hence,
he ability of the extract to inhibit lipid peroxidation in the kid-
ey, liver and lungs tissues homogenates of rats indicates its
bility to prevent and/or ameliorate oxidative damage to the
ipids in the membranes of the cells of these three important
rgans; thereby maintaining the integrity of their membrane
tructure and functionality. Furthermore, since the ROS gen-
rated by lipid peroxidation are involved in the pathogenesis of
everal other diseases such as diabetes mellitus, cardiovascular
iseases and carcinogenesis, XO inhibitors, including polyphe-
olics, could also be useful for the prevention and management
f many other diseases [44]. This may explain why T.  tetraptera
ruit has other medicinal uses as stated earlier. The lipid per-
xidation inhibitory activity of the T.  tetraptera  fruit extract
ould be attributed to its flavonoids and phenolic acids. This is
n agreement with our earlier report that Mangifera  indica  and
ucuna urens  seeds extracts rich in these two classes of phen-
lics inhibited Fe2+-induced lipid peroxidation in rat pancreas
omogenate [34].
.  Conclusion
Phenolics extract of T.  tetraptera  fruits inhibited xanthine oxi-
ase and F2+-induced lipid peroxidation in the kidney, liver and
ungs tissues of rats in  vitro. These activities could be attributed
o the combined effect of the flavonoids and phenolic acids
resent in the fruits. Therefore, T.  tetraptera  fruits might be
 promising functional food that could be explored for the pre-
ention and management of hyperuricaemia and its associated
isease conditions.
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